Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM5BP6BS2
The ENST00000265602.11(AHI1):āc.989A>Gā(p.Asp330Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0012 in 1,613,930 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/23 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D330V) has been classified as Uncertain significance.
AHI1 (HGNC:21575): (Abelson helper integration site 1) This gene is apparently required for both cerebellar and cortical development in humans. This gene mutations cause specific forms of Joubert syndrome-related disorders. Joubert syndrome (JS) is a recessively inherited developmental brain disorder with several identified causative chromosomal loci. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Oct 2008]
Verdict is Likely_benign. Variant got -3 ACMG points.
PM5
Other missense variant is known to change same aminoacid residue: Variant chr6-135457656-TC-TTATTATTTA is described in Lovd as [Pathogenic].
BP6
Variant 6-135457656-T-C is Benign according to our data. Variant chr6-135457656-T-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 215522.We mark this variant Likely_benign, oryginal submissions are: {Benign=1, Uncertain_significance=2, Likely_benign=4}.
Uncertain significance, criteria provided, single submitter
clinical testing
Illumina Laboratory Services, Illumina
Apr 27, 2017
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
Uncertain significance, criteria provided, single submitter
clinical testing
Revvity Omics, Revvity
Oct 18, 2022
- -
not provided Benign:2
Likely benign, criteria provided, single submitter
clinical testing
GeneDx
Mar 24, 2021
This variant is associated with the following publications: (PMID: 17409309, 21228398) -
Likely benign, criteria provided, single submitter
clinical testing
CeGaT Center for Human Genetics Tuebingen
Feb 01, 2023
AHI1: BP4 -
not specified Benign:1
Likely benign, criteria provided, single submitter
clinical testing
Eurofins Ntd Llc (ga)
Apr 21, 2016
- -
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter
clinical testing
Ambry Genetics
May 17, 2021
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
AHI1-related disorder Benign:1
Likely benign, no assertion criteria provided
clinical testing
PreventionGenetics, part of Exact Sciences
Mar 10, 2022
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -